The essential roles of primary cilia in heterotopic ossification
- Institution
- Mayo Clinic Rochester, MN
- Principal investigator
- Haitao Wang
- Funding
- $1.2M
- Duration
- 2023–2028
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY/ABSTRACT Heterotopic ossification (HO), a diverse pathologic process of formation of extraskeletal bone in muscle and soft tissues, can be classified into hereditary and nonhereditary (acquired) HO types. A rare and devastating form of hereditary HO is fibrodysplasia ossificans progressiva (FOP), caused by gain-of-function mutations in Activin receptor A type I (Acvr1) gene. In the nonhereditary forms, HO frequently occurs in tendons and ligaments and is commonly incited upon soft tissue trauma, orthopedic surgeries, combat-related blasts, and burns. There are currently still no effective drugs to treat HO. Our long-term goal is to decipher the mechanism(s) of HO and develop novel strategies for the clinical treatment of HO. The overall objectives are to (i) elucidate the essential roles of cilia on the Bone morphogenetic protein (BMP) signaling pathway and (ii) determine its function using novel HO models. The central hypothesis is that primary cilia play central roles in transducing normal and pathogenic BMP signaling and regulating the pathophysiological mechanism of both hereditary and nonhereditary HO. The rationale is that both hereditary and nonhereditary HO formation are primarily mediated by the BMP signaling pathway. However, it remains elusive where and how BMP signaling is transduced and regulated in cells. Primary cilia are antenna-like structures protruding from the surface of cells and are critical for proper transduction of many cellular signaling pathways. Dysfunctional primary cilia result in a broad spectrum of human diseases collectively termed ciliopathies. Our preliminary data suggest that primary cilia play central roles in transducing normal and pathogenic BMP signaling and regulate the pathophysiological mechanism(s) of HO formation. The central hypotheses will be tested by pursuing these specific aims: 1) Determine the ciliary components/pathways that govern normal and pathogenic BMP signaling pathways. 2) Determine the regulatory function of cilia in our newly established nonhereditary burn/tenotomy-induced HO mouse models that have abrogated ciliary signaling pathways. 3) Identify targets for inhibition of cilium-related pathways as the basis for treatments in hereditary HO and nonhereditary HO. The research proposed in this application is innovative because our preliminary data suggest that FOP and perhaps other HO conditions represent cilium-mediated disorders, which provides a novel perspective for future therapies. Mechanistically, we will systematically elucidate the function of cilia on BMP signaling specifically as associated with HO mouse models. The proposed research is significant, and scientifically it will build a new paradigm that primary cilium plays a central role in transducing BMP signaling in chondrogenesis and/or osteogenesis that ultimately results in both hereditary and nonhereditary HO. Clinically, targeting the cilia-mediated BMP pathway is an unexplored therapeutic strategy that could be applied not only for FOP but also for other more common forms of HO, such as post-traumatic HO.
LOADING MOONBASE SCORE
Questions for Mayo Clinic Rochester
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Mayo Clinic Rochester67
Early Detection of Mild Cognitive Impairment, Alzheimer's Disease and Other Dementias using EHR
Sunghwan Sohn · $610K · 2020–2026
- NIH · Mayo Clinic Rochester59
Targeting Cancer-Associated Fibroblasts Prevents Resistance to Chimeric Antigen Receptor T Cell Therapy
Reona Sakemura · $219K · 2022–2028
- NIH · Mayo Clinic Rochester56
Advancing MR elastography to map mechanical signatures of key AD/ADRD processes
Matthew Christopher Murphy · $433K · 2022–2027